The effect of helicobacter pylori eradication on migraine: A randomized, double blind, controlled trial

Pain Physician

Volumn 15, Issue 6, 2012, Pages 495-498

  Faraji, Fardin ^a   Zarinfar, Nader ^a   Zanjani, Afsoon Talaie ^b   Morteza, Afsaneh ^c  

^a ARAK UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c Farzan Clinical Research Institute   (Iran)

Author keywords

Helicobacter pylori; Migraine headache

Indexed keywords

CLARITHROMYCIN; METRONIDAZOLE; NORTRIPTYLINE; OMEPRAZOLE; PLACEBO; VALPROIC ACID;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MIGRAINE DISABILITY ASSESSMENT QUESTIONNAIRE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANALGESICS; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DOUBLE-BLIND METHOD; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; MIGRAINE DISORDERS; OMEPRAZOLE;

EID: 84869823462     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Alakkari A, Zullo A, O'Connor HJ. Helicobacter pylori and nonmalignant diseases. Helicobacter 2011; 1:33-37.
2. De Falco G, Rogena EA, Leoncini L. Infectious agents and lymphoma. Semin Diagn Pathol 2011; 28:178-187.
3. Tan VP, Wong BC. Helicobacter pylori and gastritis: Untangling a complex relationship 27 years on. J Gastroenterol Hepatol 2011; 1:42-45.
4. Gasbarrini G, Racco S, Franceschi F, Miele L, Cammarota G, Grieco A, Gasbarrini A. Helicobacter pylori infection: From gastric to systemic disease. Recenti Prog Med 2010; 101:27-33.
5. Krueger S, Roessner A, Kuester D. Murine models of H. pylori-induced gastritis and gastric adenocarcinoma. Pathol Res Pract 2011; 207:599-607.
6. Malfertheiner MV, Kandulski A, Schreiber J, Malfertheiner P. Helicobacter pylori infection and the respiratory system: A systematic review of the literature. Digestion 2011; 84:212-220.
7. Ruggiero P. Helicobacter pylori and inflammation. Curr Pharm Des 2010; 16:4225-4236.
8. Sugimoto M, Yamaoka Y. Review of Helicobacter pylori infection and chronic renal failure. Ther Apher Dial 2011; 15:1-9.
9. Suzuki H, Franceschi F, Nishizawa T, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection. Helicobacter 2011; 1:65-69.
10. Ciancarelli I, Di Massimo C, Tozzi-Ciancarelli MG, De Matteis G, Marini C, Carolei A. Helicobacter pylori infection and migraine. Cephalalgia 2002; 22:222-225.
11. Gabrielli M, Fiore G, Candelli M, Giacovazzo M, Pola P, Gasbarrini G, Gasbarrini A. Re: "Chronic Helicobacter pylori infection and migraine: A case-control study" (Pinessi L, Savi L, Pellicano R, et al. Headache 2000; 40:836-839). Headache 2002; 42:236-237.
12. Gasbarrini A, De Luca A, Fiore G, Franceschi F, Ojetti V V, Torre ES, Di Campli C, Candelli M, Pola R, Serricchio M, Tondi P, Gasbarrini G, Pola P, Giacovazzo M. Primary headache and Helicobacter pylori. Int J Angiol 1998; 7:310-312.
13. Kemper RH, Meijler WJ, Korf J, Ter Horst GJ. Migraine and function of the immune system: A meta-analysis of clinical literature published between 1966 and 1999. Cephalalgia 2001; 21:549-557.
14. Dahlof CG. Measuring disability and quality of life in migraine. Drugs Today (Barc) 2003; 39:17-23.
15. Dowson AJ. Assessing the impact of migraine. Curr Med Res Opin 2001; 17:298-309.
16. Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology 2001; 56:S20-S28.
17. Pinessi L, Savi L, Pellicano R, Rainero I, Valfrè W, Gentile S, Cossotto D, Rizzetto M, Ponzetto A. Chronic Helicobacter pylori infection and migraine: A case-control study. Headache 2000; 40:836-839.
18. Tunca A, Turkay C, Tekin O, Kargili A, Erbayrak M. Is Helicobacter pylori infection a risk factor for migraine? A case-control study. Acta Neurol Belg 2004; 104:161-164.
19. Hosseinzadeh M, Khosravi A, Saki K, Ranjbar R. Evaluation of Helicobacter pylori infection in patients with common migraine headache. Arch Med Sci 2011; 7:844-849.
20. Gasbarrini A, De Luca A, Fiore G, Gambrielli M, Franceschi F, Ojetti V, Torre ES, Gasbarrini G, Pola P, Giacovazzo M. Beneficial effects of Helicobacter pylori eradication on migraine. Hepatogastroenterology 1998; 45:765-770.
21. Hong L, Zhao Y, Han Y, Guo W, Wang J, Li X, Han Y, Fan D. Reversal of migraine symptoms by Helicobacter pylori eradication therapy in patients with hepatitis-B-related liver cirrhosis. Helicobacter 2007; 12:306-308.
22. Mavromichalis I, Zaramboukas T, Giala MM. Migraine of gastrointestinal origin. Eur J Pediatr 1995; 154:406-410.
23. Yiannopoulou KG, Efthymiou A, Karydakis K, Arhimandritis A, Bovaretos N, Tzivras M. Helicobacter pylori infection as an environmental risk factor for migraine without aura. J Headache Pain 2007; 8:329-333.
24. Tunca A, Ardicoglu Y, Kargili A, Adam B. Migraine, Helicobacter pylori, and oxidative stress. Helicobacter 2007; 12:59-62.
25. Gasbarrini A, Gabrielli M, Fiore G, Candelli M, Bartolozzi F, De Luca A, Cremonini F, Franceschi F, Di Campli C, Armuzzi A, Ojetti V, Serricchio M, Pola R, Gasbarrini G, Giacovazzo M, Pola P. Association between Helicobacter pylori cytotoxic type I CagA-positive strains and migraine with aura. Cephalalgia 2000; 20:561-565.